Investigating the role of a protein in motor neuron degeneration in ALS
Role of FABP7 in ALS models
This study is looking at how lowering a protein called FABP7 might help protect nerve cells in people with ALS, with the hope of finding new ways to treat the condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Wisconsin-Madison NIH-funded |
| Lab location | 1 site (Madison, United States) |
| Project ID | NIH-11091530 on NIH RePORTER |
What this research studies
This research aims to understand how reducing the expression of fatty acid-binding protein 7 (FABP7) can help prevent the degeneration of motor neurons in models of amyotrophic lateral sclerosis (ALS). The study will explore the role of FABP7 in lipid metabolism and inflammation, which are critical factors in ALS pathology. By examining how FABP7 interacts with fatty acids and other lipids, researchers hope to uncover new therapeutic targets for ALS. Patients may benefit from insights gained about the mechanisms of motor neuron degeneration and potential new treatment strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults diagnosed with amyotrophic lateral sclerosis (ALS).
Not a fit: Patients with other neurological disorders or those not diagnosed with ALS may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic approaches that slow down or prevent motor neuron degeneration in ALS patients.
How similar studies have performed: Previous research has shown promising results in targeting fatty acid-binding proteins for therapeutic purposes, indicating potential success for this approach.
Where this research is happening
Madison, United States
- University of Wisconsin-Madison — Madison, United States (Active)
Researchers
- Principal investigator: Vargas, Marcelo R — University of Wisconsin-Madison
- Study coordinator: Vargas, Marcelo R
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.